Edition:
United States

Tandem Diabetes Care Inc (TNDM.OQ)

TNDM.OQ on NASDAQ Stock Exchange Global Market

2.51USD
12 Dec 2017
Change (% chg)

-- (--)
Prev Close
$2.51
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
87,128
52-wk High
$30.00
52-wk Low
$2.15

Latest Key Developments (Source: Significant Developments)

Tandem Diabetes Care Announces Retirement Of CFO And Successor Appointment
Thursday, 7 Dec 2017 04:30pm EST 

Dec 7 (Reuters) - Tandem Diabetes Care Inc ::TANDEM DIABETES CARE ANNOUNCES RETIREMENT OF CFO AND SUCCESSOR APPOINTMENT.SAYS CFO JOHN CAJIGAS TO RETIRE, EFFECTIVE DECEMBER 31, 2017.TANDEM DIABETES CARE SAYS LEIGH VOSSELLER, WILL BE PROMOTED TO CFO, EFFECTIVE JANUARY 1, 2018.  Full Article

Tandem Diabetes Care reports Q3 sales of $27 million
Thursday, 26 Oct 2017 04:05pm EDT 

Oct 26 (Reuters) - Tandem Diabetes Care Inc :Tandem Diabetes Care reports third quarter 2017 financial results.Q3 sales $27 million versus I/B/E/S view $25.9 million.Tandem Diabetes Care Inc - qtrly loss per share $3.09‍​.Tandem Diabetes Care Inc - sees ‍fy 2017 GAAP sales to be in range of $100 million to $105 million.Tandem Diabetes Care Inc - sees ‍fy 2017 non-GAAP sales to be in range of $95 million to $100 million​.Q3 earnings per share view $-3.74, revenue view $25.9 million -- Thomson Reuters I/B/E/S.  Full Article

‍Tandem Diabetes Care to provide all t:slim X2 insulin pump features approved in 2018 to users at no cost
Tuesday, 24 Oct 2017 04:30pm EDT 

Oct 24 (Reuters) - Tandem Diabetes Care Inc ::‍Tandem Diabetes Care to provide all t:slim x2 insulin pump features approved in 2018 to users at no cost, expands existing dexcom welcome offer for animas customers​.Tandem diabetes care inc - ‍tandem and Dexcom are now extending terms of their welcome programs for animas customers through march 31, 2018​.  Full Article

Empery Asset Management reports 5.63 pct passive stake in Tandem Diabetes Care
Friday, 20 Oct 2017 02:51pm EDT 

Oct 20 (Reuters) - Empery Asset Management Lp::Empery Asset Management Lp reports 5.63 pct passive stake in Tandem Diabetes Care Inc <<>> as of Oct 13 - SEC filing‍​.  Full Article

Tandem Diabetes Care sees Q3 sales of about $26.5 mln to $27.5 mln
Friday, 13 Oct 2017 06:27am EDT 

Oct 13 (Reuters) - Tandem Diabetes Care Inc ::Sees Q3 sales about $26.5 million to $27.5 million - sec filing.Tandem Diabetes - expect seasonality to have similar impact on sales in 2017.Tandem - ‍do not expect funding from completed or proposed financing to fully address substantial doubt about co's ability to continue as a going concern​.Tandem Diabetes-expectation of seasonality impact excludes about $3.5 million deferred sales&upgrade fees received with technology program expected in q3​.Tandem Diabetes Care Inc- ‍expect we will be required to raise additional capital in order to continue as a going concern​.  Full Article

Tandem Diabetes Care‍ shareholders approv reverse stock split
Monday, 9 Oct 2017 09:00am EDT 

Oct 9 (Reuters) - Tandem Diabetes Care Inc :Tandem Diabetes Care Inc- ‍ shareholders subsequently approved reverse stock split at a ratio of 1-for-10​.  Full Article

Tandem Diabetes Care announces FDA approval, launch of t:slim X2 insulin pump with Dexcom G5 mobile CGM integration
Monday, 28 Aug 2017 08:30am EDT 

Aug 28 (Reuters) - Tandem Diabetes Care Inc ::Tandem Diabetes care announces FDA approval and launch of t:slim X2 insulin pump with Dexcom G5 mobile CGM integration.Tandem diabetes care inc- ‍t:slim X2 pump with Dexcom G5 mobile CGM integration is approved for ages 6 and older​.  Full Article

Tandem Diabetes Care begins enrollment for 1st touchscreen insulin pump with PGLS
Tuesday, 15 Aug 2017 08:30am EDT 

Aug 15 (Reuters) - Tandem Diabetes Care Inc :Tandem Diabetes Care begins enrollment in pivotal trial for first touchscreen insulin pump with predictive low glucose suspend (PLGS).Tandem Diabetes Care Inc - ‍remain on track to submit t:slim X2 pump with predictive low glucose suspend to FDA in early 2018​.Tandem Diabetes - preparing to launch in summer of 2018, plan to make new feature accessible for existing t:slim X2 customers via remote software update​.  Full Article

Tandem Diabetes Care Q2 sales $21.3 million
Thursday, 27 Jul 2017 04:00pm EDT 

July 27 (Reuters) - Tandem Diabetes Care Inc :Tandem Diabetes Care reports second quarter 2017 financial results.Q2 sales $21.3 million versus I/B/E/S view $21.7 million.Sees FY 2017 sales $100 million to $107 million.FY2017 revenue view $102.9 million -- Thomson Reuters I/B/E/S.  Full Article

Tandem Diabetes Care Q2 net loss per share $0.44
Thursday, 27 Jul 2017 04:00pm EDT 

July 27 (Reuters) - Tandem Diabetes Care Inc ::Tandem Diabetes Care reports second quarter 2017 financial results.Q2 sales $21.3 million versus I/B/E/S view $21.7 million.Sees non-GAAP FY 2017 sales $100 million to $107 million .FY2017 revenue view $102.9 million -- Thomson Reuters I/B/E/S.Qtrly net loss per share $0.44 .  Full Article